The first death of a patient involved in a trial of gene therapy for rheumatoid arthritis is discussed in a commentary in the current issue of Arthritis Research & Therapy. Prof Chris Evans and colleagues have collated information about the clinical trial – put on hold following the patient’s death and since restarted with a… Read more »
Journal of Hematology & Oncology is a new open access, independent journal launched today by BioMed Central. The journal aims to bring together research from these two closely intertwined, rapidly evolving fields to allow fast dissemination of information to the widest possible global audience. Journal of Hematology & Oncology aims not to specialize, rather to… Read more »
We are pleased to announce the move of Journal of Experimental & Clinical Cancer Research (JECCR) to BioMed Central’s open access publishing platform. Overseen by Editor-in-Chief Mauro Castelli and supported by an international Editorial Board, JECCR has joined BioMed Central in order to provide rapid dissemination of scientific results to the widest possible global audience…. Read more »
"Clinicians have the privilege of dealing with individuals in all their complexity and magnificence. Every person, every "case" can teach us something." This idea, explained by the Editor-in-Chief, Richard Smith in his launch editorial, is the philosophy behind the new Cases Journal, launched this week. The journal will publish case reports from any area of… Read more »